Clinical study of posterior chamber lens KI-362-YP in patients with senile cataract

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080225356

Enrollment

Registered

2020-08-26

Start date

2020-09-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Senile cataract

Interventions

investigational material(s) Generic name etc : KI-362-YP(Intraocular lens) INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational mater

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Senile (age-related) cataract patients for which ultrasonic emulsification suction is indicated etc.

Exclusion criteria

Exclusion criteria: - Patients with a disease in which the symptoms worsen during and/or after surgery in the target eye - Patients who are participating in or will participate in other clinical trials that may affect the evaluation of this clinical trial - Patients who are judged to be inappropriate by the principal investigator or the sub-investigator etc.

Design outcomes

Primary

Measure	Time frame
efficacy Visual acuity after surgery	—

Secondary

Measure	Time frame
safety efficacy Visual acuity, adverse events, etc.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026